WHO ICTRP trial
Eine 8-wöchige, monozentrische, baseline-kontrollierte offene Studie zur…
EUCTR2010-020433-13-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-020433-13-DE |
|---|---|
| Public title | Eine 8-wöchige, monozentrische, baseline-kontrollierte offene Studie zur Evaluierung des Einflusses einer “Single pill combination” auf die Blutdrucksenkung bei Patienten mit nicht-kontrolliertem Blutdruck unter freier Therapie - AMBITIOUS |
| Scientific title | Eine 8-wöchige, monozentrische, baseline-kontrollierte offene Studie zur Evaluierung des Einflusses einer “Single pill combination” auf die Blutdrucksenkung bei Patienten mit nicht-kontrolliertem Blutdruck unter freier Therapie - AMBITIOUS |
| Primary sponsor | Charité-Universitätsmedizin Berlin |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Hypertension MedDRA version: 12.1 Level: LLT Classification code 10015488 Term: Essential hypertension |
| Interventions | Trade Name: Rasilez HCT 150mg/25mg Pharmaceutical Form: Film-coated tablet INN or Proposed INN: ALISKIREN CAS Number: 173334571 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 150- INN or Proposed INN… |
| Registration date | Nov 26, 2010 |
| Secondary IDs | CCB-CRC-2010-02 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: